SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]
Intangible assets useful life	5 years		5 years
Amortization expenses			$ 120,000	$ 120,000
Intangible assets unamortized balance	$ 262,000		262,000		$ 382,000
Impairment of intangible assets			$ 0	$ 0
Potentially dilutive securities			278,188	150,000
Proceeds from deferred offering costs			$ 872,000
Deferred tax assets valuation allowance, percentage	100.00%		100.00%		100.00%
Unrecognized tax benefits	$ 0		$ 0
Accrued interest					$ 0
Patent expenses	369,000	$ 254,000	655,000	550,000
Research and development costs	14,000	$ 33,000	242,000	75,000
Patents [Member]
Restructuring Cost and Reserve [Line Items]
Patent expenses			123,000	$ 130,000
IPO [Member]
Restructuring Cost and Reserve [Line Items]
Deferred offering costs	$ 872,000		872,000		$ 482,000
Proceeds from deferred offering costs			$ 872,000
Restricted Stock Units (RSUs) [Member]
Restructuring Cost and Reserve [Line Items]
Unvested restricted stock	80,000		80,000
Enviro Threapeutics Inc [Member]
Restructuring Cost and Reserve [Line Items]
Acquisition cost						$ 800,000